Kelly Shanahan, Director at METAvivor Research And Support, shared a post by Oscar Tahuahua, Medical Oncology Fellow at the National Cancer Institute of Mexico, on X, adding:
“Given that up to half of people with metastatic HER2+ or TNBC will develop brain mets – and an increasing number of people with HR+ as well, as newer treatments keep us alive longer – the answer imo is Yes, screen for brain mets!”
Oscar Tahuahua: Prospective Study of Brain Metastasis Imaging in Advanced HER2-Positive and TNBC
